ITRM
Price
$0.42
Change
+$0.01 (+2.44%)
Updated
Dec 3 closing price
Capitalization
22.02M
98 days until earnings call
Intraday BUY SELL Signals
PLUR
Price
$3.42
Change
+$0.06 (+1.79%)
Updated
Dec 3 closing price
Capitalization
30.63M
Intraday BUY SELL Signals
Interact to see
Advertisement

ITRM vs PLUR

Header iconITRM vs PLUR Comparison
Open Charts ITRM vs PLURBanner chart's image
Iterum Therapeutics
Price$0.42
Change+$0.01 (+2.44%)
Volume$480.88K
Capitalization22.02M
Pluri
Price$3.42
Change+$0.06 (+1.79%)
Volume$14.64K
Capitalization30.63M
ITRM vs PLUR Comparison Chart in %
ITRM
Daily Signal:
Gain/Loss:
PLUR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ITRM vs. PLUR commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITRM is a StrongBuy and PLUR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (ITRM: $0.42 vs. PLUR: $3.36)
Brand notoriety: ITRM and PLUR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ITRM: 36% vs. PLUR: 6%
Market capitalization -- ITRM: $22.02M vs. PLUR: $30.63M
ITRM [@Biotechnology] is valued at $22.02M. PLUR’s [@Biotechnology] market capitalization is $30.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ITRM’s FA Score shows that 1 FA rating(s) are green whilePLUR’s FA Score has 0 green FA rating(s).

  • ITRM’s FA Score: 1 green, 4 red.
  • PLUR’s FA Score: 0 green, 5 red.
According to our system of comparison, ITRM is a better buy in the long-term than PLUR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ITRM’s TA Score shows that 5 TA indicator(s) are bullish while PLUR’s TA Score has 4 bullish TA indicator(s).

  • ITRM’s TA Score: 5 bullish, 2 bearish.
  • PLUR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ITRM is a better buy in the short-term than PLUR.

Price Growth

ITRM (@Biotechnology) experienced а -4.40% price change this week, while PLUR (@Biotechnology) price change was -10.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

ITRM is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLUR($30.6M) has a higher market cap than ITRM($22M). PLUR YTD gains are higher at: -21.404 vs. ITRM (-76.328). PLUR (-20.22M) and ITRM (-20.51M) have comparable annual earnings (EBITDA) . PLUR has more cash in the bank: 26.3M vs. ITRM (13M). PLUR (31.2M) and ITRM (32.6M) have identical debt. PLUR has higher revenues than ITRM: PLUR (1.03M) vs ITRM (0).
ITRMPLURITRM / PLUR
Capitalization22M30.6M72%
EBITDA-20.51M-20.22M101%
Gain YTD-76.328-21.404357%
P/E RatioN/AN/A-
Revenue01.03M-
Total Cash13M26.3M49%
Total Debt32.6M31.2M104%
FUNDAMENTALS RATINGS
ITRM vs PLUR: Fundamental Ratings
ITRM
PLUR
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
95
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9464
P/E GROWTH RATING
1..100
2100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ITRM's Valuation (62) in the Biotechnology industry is somewhat better than the same rating for PLUR (95). This means that ITRM’s stock grew somewhat faster than PLUR’s over the last 12 months.

ITRM's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PLUR (100). This means that ITRM’s stock grew similarly to PLUR’s over the last 12 months.

ITRM's SMR Rating (100) in the Biotechnology industry is in the same range as PLUR (100). This means that ITRM’s stock grew similarly to PLUR’s over the last 12 months.

PLUR's Price Growth Rating (64) in the Biotechnology industry is in the same range as ITRM (94). This means that PLUR’s stock grew similarly to ITRM’s over the last 12 months.

ITRM's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for PLUR (100). This means that ITRM’s stock grew significantly faster than PLUR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ITRMPLUR
RSI
ODDS (%)
Bullish Trend 7 days ago
72%
Bullish Trend 7 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
84%
Bullish Trend 7 days ago
70%
Momentum
ODDS (%)
N/A
Bearish Trend 7 days ago
90%
MACD
ODDS (%)
Bullish Trend 7 days ago
86%
Bullish Trend 7 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
82%
Bearish Trend 7 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 9 days ago
74%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 11 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
78%
Bearish Trend 7 days ago
90%
Aroon
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 7 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ITRM
Daily Signal:
Gain/Loss:
PLUR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRAI183.785.23
+2.93%
CRA International
GSK48.291.10
+2.34%
GSK plc
FINW18.00-0.01
-0.06%
FinWise Bancorp
RAL48.73-0.05
-0.10%
Ralliant Corporation
PSHG2.37-0.02
-0.84%
Performance Shipping

ITRM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITRM has been loosely correlated with SNTI. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ITRM jumps, then SNTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITRM
1D Price
Change %
ITRM100%
-7.10%
SNTI - ITRM
35%
Loosely correlated
+4.37%
TARA - ITRM
35%
Loosely correlated
-7.79%
ENSC - ITRM
35%
Loosely correlated
-4.57%
RGNX - ITRM
34%
Loosely correlated
-3.10%
ORMP - ITRM
34%
Loosely correlated
+0.36%
More

PLUR and

Correlation & Price change

A.I.dvisor tells us that PLUR and ENSC have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PLUR and ENSC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLUR
1D Price
Change %
PLUR100%
-0.30%
ENSC - PLUR
31%
Poorly correlated
-4.57%
ITRM - PLUR
30%
Poorly correlated
-7.10%
NGNE - PLUR
30%
Poorly correlated
-6.01%
KOD - PLUR
29%
Poorly correlated
+0.32%
BNTX - PLUR
29%
Poorly correlated
-1.42%
More